Through this new contract, Premier members will now have access to special pricing for HemCon dressings, which are intended to improve patient care following diagnostic and interventional vascular access procedures. The dressings offer safe and fast hemostasis with an effective antibacterial barrier against a wide spectrum of microorganisms including MRSA, VRE and Acinetobacter baumannii that may help to reduce the risk of hospital acquired infections.

“HemCon is pleased to be included as a contracted supplier for Premier. Our company is committed to creating new healthcare products that drive improved patient safety and better, clinical results. We’re excited that Premier will make our revolutionary hemostatic products available to their members,” said HemCon Chief Executive Officer John W. Morgan.

The hemostatic HemCon Patch, designed for vascular closure following diagnostic and interventional cardiac catheterization procedures, was only such device to be selected for the Premier’s inaugural Innovation Celebration.